Yuanlong He Selected Research

Pharmaceutical Preparations

10/2016

5-Azacytidine suppresses EC9706 cell proliferation and metastasis by upregulating the expression of SOX17 and CDH1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuanlong He Research Topics

Disease

5	Neoplasms (Cancer) 01/2019 - 03/2011
3	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2016
2	Stomach Neoplasms (Stomach Cancer) 01/2019 - 01/2016
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Carcinogenesis 01/2022
1	Wounds and Injuries (Trauma) 07/2020
1	Esophageal Neoplasms (Esophageal Cancer) 10/2016
1	Breast Neoplasms (Breast Cancer) 10/2016
1	Colonic Neoplasms (Colon Cancer) 10/2016
1	Melanoma (Melanoma, Malignant) 10/2016
1	Infections 01/2015
1	Adenocarcinoma 12/2012
1	Liver Cirrhosis (Hepatic Cirrhosis) 07/2008

Drug/Important Bio-Agent (IBA)

2	Small Interfering RNA (siRNA)IBA 10/2016 - 01/2016
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022
1	CytokinesIBA 07/2020
1	Therapeutic UsesIBA 07/2020
1	Indomethacin (Indometacin)FDA LinkGeneric 07/2020
1	MicroRNAs (MicroRNA)IBA 01/2019
1	VinculinIBA 01/2019
1	Biological ProductsIBA 10/2016
1	Pharmaceutical PreparationsIBA 10/2016
1	Azacitidine (5 Azacytidine)FDA Link 10/2016
1	Glycoproteins (Glycoprotein)IBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Neuropilin-1IBA 01/2016
1	Bone SubstitutesIBA 01/2015
1	Drug CarriersIBA 01/2015
1	Gentamicins (Gentamicin)FDA LinkGeneric 01/2015
1	Durapatite (Hydroxylapatite)IBA 01/2015
1	SurvivinIBA 12/2012
1	EpitopesIBA 12/2012
1	Peptides (Polypeptides)IBA 12/2012
1	VaccinesIBA 12/2012
1	hydrogen sulfite (bisulfite)IBA 03/2011
1	Decitabine FDA Link 03/2011
1	Proteins (Proteins, Gene)FDA Link 03/2011
1	Messenger RNA (mRNA)IBA 03/2011

Therapy/Procedure

1	Oral Administration 07/2020
1	Immunotherapy 12/2012
1	Aftercare (After-Treatment) 03/2011
1	Therapeutics 07/2008
1	Transplantation 07/2008